Rare diseases
Investigational molecules
Locations
Study on Long-Term Safety of Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease
PortugalStudy on TAK-330 for Reversing Anticoagulation in Patients on Factor Xa Inhibitors Needing Urgent Surgery
PortugalStudy Comparing Mosunetuzumab and Lenalidomide with Other Treatments for Patients with Relapsed or Refractory Marginal Zone Lymphoma
PortugalPhase III Trial Comparing ABVD vs A2VD Treatment With PET-Guided Radiation Therapy for Patients With Early Stage Hodgkin Lymphoma
PortugalLong-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer
PortugalStudy Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma
PortugalStudy on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis
PortugalStudy on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine
PortugalStudy of isatuximab, belumosudil and dexamethasone combination treatment for patients with relapsed or refractory multiple myeloma
PortugalStudy of isatuximab, pomalidomide and dexamethasone combination for patients with relapsed or refractory multiple myeloma
PortugalStudy of isatuximab, evorpacept and dexamethasone combination therapy for patients with relapsed or refractory multiple myeloma
PortugalStudy on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia
PortugalTell us about your condition – we search every trial in Europe and connect you with the right site.
